Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Logistics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1745009

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1745009

Bio-pharma Logistics

PUBLISHED:
PAGES: 231 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Bio-pharma Logistics Market to Reach US$172.9 Billion by 2030

The global market for Bio-pharma Logistics estimated at US$109.6 Billion in the year 2024, is expected to reach US$172.9 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$104.2 Billion by the end of the analysis period. Growth in the Non-Cold Chain Logistics segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.8 Billion While China is Forecast to Grow at 7.7% CAGR

The Bio-pharma Logistics market in the U.S. is estimated at US$28.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.8 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Bio-pharma Logistics Market - Key Trends & Drivers Summarized

Why Is Bio-pharma Logistics Emerging as a Strategic Pillar for Product Integrity, Cold Chain Compliance, and Global Therapeutic Reach?

Bio-pharma logistics has evolved into a mission-critical function within the life sciences value chain, underpinning the secure, timely, and temperature-controlled distribution of high-value pharmaceuticals, biologics, vaccines, and cell and gene therapies. With increasing product complexity and sensitivity, logistics now plays a central role in safeguarding therapeutic efficacy, regulatory compliance, and market access. From first-mile API transport to last-mile clinical delivery, logistics providers are being integrated into broader commercialization and supply continuity strategies.

The rise of temperature-sensitive biologics-including monoclonal antibodies, mRNA vaccines, and CAR-T therapies-has amplified the importance of end-to-end cold chain logistics. These products require stringent temperature ranges (typically 2-8°C, -20°C, or even cryogenic storage at -80°C) and must be monitored in real time to prevent thermal excursions that can compromise product viability. The expansion of decentralized clinical trials, direct-to-patient delivery models, and global vaccine programs has placed further demands on logistics infrastructure, visibility, and traceability.

Beyond temperature control, bio-pharma logistics must address challenges related to product shelf life, regulatory harmonization, customs clearance, and security in transit. With biologics and advanced therapies commanding high economic and therapeutic value, any disruption in the logistics chain can have far-reaching clinical and financial consequences. As a result, pharmaceutical companies are re-evaluating logistics as a strategic capability-selecting partners not just on cost but on quality assurance, compliance strength, and technological readiness.

How Are Cold Chain Technologies, Real-Time Visibility, and Risk Mitigation Strategies Reshaping Logistics Capabilities in Bio-pharma?

Cold chain innovation is at the forefront of logistics transformation. Advanced packaging solutions-such as phase-change materials, vacuum-insulated panels, and reusable thermal shippers-are being deployed to maintain temperature integrity over extended transit times and varied climatic conditions. Cryogenic containers with dry vapor nitrogen technology are increasingly used for cell and gene therapy shipments, where ultra-low temperature stability is non-negotiable.

Real-time visibility tools are becoming standard across critical lanes, with IoT-enabled data loggers, GPS trackers, and cloud-based dashboards providing granular insights into location, temperature, shock, light, and humidity. These tools allow logistics managers to intervene proactively in case of deviations, reroute sensitive shipments, and maintain audit trails for regulatory documentation. Integration with warehouse management systems (WMS), transport management systems (TMS), and blockchain-based platforms further enhances traceability and chain-of-custody assurance.

Risk mitigation is a key priority in bio-pharma logistics, particularly in high-risk geographies or during pandemic-level disruptions. Contingency planning, route qualification, dual-vendor cold chain setups, and redundant storage nodes are increasingly embedded in logistics strategies to ensure continuity of supply. Regulatory agencies such as the FDA, EMA, and WHO are mandating stricter controls on transport validation, temperature mapping, and deviation response protocols-reinforcing the need for logistics partners with GxP-compliant operations and pharmaceutical-grade quality systems.

Which Therapeutic Segments, Global Distribution Networks, and Strategic Partnerships Are Driving Demand for Specialized Bio-pharma Logistics?

Advanced therapies-including cell and gene therapies, personalized cancer vaccines, and RNA-based biologics-are the primary growth drivers in the bio-pharma logistics market. These therapies often have narrow windows of viability, require just-in-time delivery models, and are produced in centralized facilities with global patient bases. The surge in clinical trials across immuno-oncology, rare diseases, and next-generation vaccines is further increasing the volume and complexity of biologics moving through the logistics chain.

Global distribution networks are adapting to meet demand from emerging bio-clusters in Asia-Pacific, the Middle East, and Latin America, which are expanding manufacturing and clinical trial operations. Logistics hubs with GDP-certified facilities, regional cold storage, and multi-modal integration are being strategically established to reduce transit risk and enable faster time-to-therapy. North America and Western Europe remain central nodes, but decentralization and localization of manufacturing are prompting a shift toward more agile and distributed logistics architectures.

Strategic partnerships between pharma companies, 3PL providers, packaging vendors, and technology enablers are redefining the logistics ecosystem. Co-development of route validation protocols, shared risk models, and digital integration platforms is enabling end-to-end visibility and performance-based logistics management. As pharma manufacturers move toward leaner, demand-driven supply chains, logistics partners are being embedded earlier in planning cycles to co-design solutions tailored to specific therapy profiles and regulatory pathways.

What Are the Factors Driving Growth in the Bio-pharma Logistics Market?

The bio-pharma logistics market is expanding as the life sciences sector transitions toward complex, temperature-sensitive, and patient-centric therapies that demand high-precision, compliant logistics solutions. Logistics is now a critical enabler of therapeutic success, patient safety, and commercial scalability.

Key growth drivers include the proliferation of cold chain-dependent biologics and advanced therapies, expanding global clinical trials, regulatory mandates for end-to-end visibility, and rising demand for decentralized, agile delivery models. Technological innovation, strategic outsourcing, and vertically integrated service models are further accelerating market evolution.

As biopharma pipelines shift toward individualized, high-value therapeutics, could logistics become the competitive differentiator-transforming from a backend function into a value-generating, risk-mitigating, and innovation-aligned pillar of next-generation pharmaceutical delivery?

SCOPE OF STUDY:

The report analyzes the Bio-pharma Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Cold Chain Logistics, Non-Cold Chain Logistics); Service Type (Transportation, Warehousing, Packaging, Other Service Types); Application (Biologics, Prescribed Drugs, Over-the-Counter Medicines, Raw Materials & Bulk Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agility Logistics
  • Air Canada Cargo
  • AmerisourceBergen Corporation
  • Biocair
  • Cavalier Logistics
  • CEVA Logistics
  • DB Schenker
  • DHL Global Forwarding
  • FedEx Corporation
  • Kerry Logistics Network Limited
  • Kuehne + Nagel
  • LifeConEx
  • Marken (a UPS Company)
  • Nippon Express
  • SF Express
  • Sofrigam Group
  • United Parcel Service (UPS)
  • VersaCold Logistics Services
  • World Courier
  • Yusen Logistics

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP34706

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bio-pharma Logistics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Demand for Temperature-Sensitive Biologics Throws the Spotlight on Specialized Bio-Pharma Logistics
    • Growth in Cell and Gene Therapy Markets Spurs Investment in Ultra-Cold Chain and Cryogenic Transportation
    • OEM Integration of Real-Time Monitoring and GPS Tracking Technologies Enhances Shipment Visibility and Integrity
    • Expansion of Just-in-Time Manufacturing and Direct-to-Patient Delivery Models Fuels Demand for Agile Logistics
    • OEM Focus on Lane Qualification, Regulatory Compliance, and GDP Certification Strengthens Provider Credibility
    • Growth in Biologics and Clinical Trial Logistics Drives Need for Time-Critical, High-Compliance Transport Networks
    • Adoption of Blockchain and Data Logging Solutions Enhances Chain-of-Custody Verification
    • Strategic Placement of Biopharma Logistics Hubs Near Manufacturing and Clinical Trial Centers Improves Responsiveness
    • Rise of Biopharma Outsourcing and Global CDMO Partnerships Supports 3PL and 4PL Market Expansion
    • Investment in Reverse Logistics and Packaging Reusability Supports Sustainability Goals in Pharmaceutical Transport
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bio-pharma Logistics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bio-pharma Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Non-Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Raw Materials & Bulk Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Raw Materials & Bulk Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prescribed Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Prescribed Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Over-the-Counter Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Over-the-Counter Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Warehousing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Warehousing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • CHINA
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Bio-pharma Logistics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Bio-pharma Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio-pharma Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Bio-pharma Logistics by Type - Cold Chain Logistics and Non-Cold Chain Logistics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Bio-pharma Logistics by Type - Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-Cold Chain Logistics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Bio-pharma Logistics by Application - Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Bio-pharma Logistics by Application - Percentage Breakdown of Value Sales for Raw Materials & Bulk Pharmaceuticals, Other Applications, Biologics, Prescribed Drugs and Over-the-Counter Medicines for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Bio-pharma Logistics by Service Type - Transportation, Warehousing, Packaging and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Bio-pharma Logistics by Service Type - Percentage Breakdown of Value Sales for Transportation, Warehousing, Packaging and Other Service Types for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!